Abstract The 2014 World Health Organization (WHO) guidelines for postexposure
prophylaxis (PEP) developed recommendations for PEP irrespective of exposure source in …

Guidelines for antiretroviral (ARV) prophylaxis following high-risk exposure (postexposure
prophylaxis—PEP) to human immunodeficiency virus (HIV) date to 1990, when the US …

Methods The guideline was developed by the Biomedical HIV Prevention Working Group of
the CIHR Canadian HIV Trials Network, with funding from the Canadian Institutes of Health …

Abstract The 2014 World Health Organization guidelines for human immunodeficiency virus
postexposure prophylaxis (PEP) are the first to combine recommendations for all …

Abstract Background. During a World Health Organization–convened Guideline
Development Group meeting, recommendations for postexposure prophylaxis (PEP) for …

We present the updated British Association for Sexual Health and HIV (BASHH) guidelines
for post‐exposure prophylaxis (PEP) to HIV following sexual exposures, occupational …

Postexposure prophylaxis (PEP) with antiretroviral medication has been used as an HIV-
prevention strategy for nearly 20 years. The fact that approximately 50 000 new HIV …

Methods: Four major databases were searched together with conference abstract databases
from inception to 1 December 2013, updated in PubMed on 1 June 2014. Randomized and …

Daily use of coformulated tenofovir and emtricitabine for HIV pre-exposure prophylaxis
(PrEP) by populations at high risk of HIV infection is now recommended in guidelines from …

Data supporting the efficacy of HIV postexposure prophylaxis (PEP) come largely from a
small number of older studies and case reports in health care workers, studies of …